高级检索
当前位置: 首页 > 详情页

C24H20N2O7, A NOVEL ISONICOTINAMIDE DERIVATIVE, REGULATES THE PROLIFERATION AND APOPTOSIS OF HepG2 CELLS THROUGH REGULATION OF AUTOPHAGY, ROS PRODUCTION AND THE ER

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Clin Nutr, Kunming 650032, Peoples R China [2]Kunming Med Univ, Sch Publ Hlth, Kunming 650500, Peoples R China [3]Kunming Med Univ, Sch Nursing, Kunming 650500, Peoples R China [4]Kunming Med Univ, Affiliated Hosp 3, Yunnan Canc Ctr, Dept, Kunming 650100, Peoples R China
出处:
ISSN:

关键词: liver cancer HepG2 anticancer autophagy reactive oxygen species endoplasmic reticulum

摘要:
This study explored the anticancer activity of C24H20N2O7 [(E)-N-(1-(6-acetyl-7,9-dihydroxy-8,9b-dimethyl-1,3-dioxo-3,9b-dihydrodibenzo[b,D]furan-2(1-h)-alkylene)ethyl)isonicotinamide], a novel chemical compound modified by esterification of C18H17NO6. MTT assays, colony formation assays, and flow cytometry analyses were performed to investigate the effect of C24H20N2O7 on the proliferation and apoptosis of HepG2 cells in vitro. A xenograft model in nude mice using HepG2 cells was established to validate the effects of C24H20N2O7 in vitro. The results revealed that the proliferation inhibition rate and the apoptosis rate of HepG2 cells were significantly increased in vitro compared with the control group. C24H20N2O7 treatment also inhibited the volume and mass of HepG2 cell mouse xenografts in vivo, and the body weight and the primary organ coefficient did not differ significantly from the control group. C24H20N2O7 may exert its effects through regulation of autophagy, reactive oxygen species, and endoplasmic reticulum regulated apoptosis. These results indicated that C24H20N2O7 inhibited the proliferation of HepG2 cells and promoted their apoptosis, whilst exhibiting low toxicity in vitro and in vivo.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 4 区 医学
小类 | 4 区 药学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 药学
JCR分区:
出版当年[2022]版:
Q4 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Clin Nutr, Kunming 650032, Peoples R China [2]Kunming Med Univ, Sch Publ Hlth, Kunming 650500, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82182 今日访问量:0 总访问量:679 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号